Results 131 to 140 of about 568,486 (233)

Biosimilars in diabetic macular edema: Promise, progress, and pitfalls. [PDF]

open access: yesIndian J Ophthalmol
Jain V   +4 more
europepmc   +1 more source

Critical appraisal of ranibizumab in the treatment of diabetic macular edema

open access: yes, 2013
Michael W StewartDepartment of Ophthalmology, Mayo School of Medicine, Jacksonville, FL, USAAbstract: Diabetic retinopathy is the leading cause of blindness among individuals of working age in industrialized nations, with most of the vision loss ...
Stewart MW
core  

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study

open access: yes, 2017
Alexei N Kulikov, Sergei V Sosnovskii, Roman D Berezin, Dmitrii S Maltsev, Dzhambulat H Oskanov, Nikolai A Gribanov Department of Ophthalmology, Military Medical Academy, St Petersburg, Russia Purpose: To study vitreoretinal interface (VRI ...
Oskanov DH   +5 more
core  

Use of antivascular endothelial growth factor for diabetic macular edema

open access: yes, 2010
Rushmia Karim, Benjamin TangUniversity of Sydney School of Public Health, Concord Repatriation General Hospital, Concord, NSW, AustraliaBackground: Diabetic macular edema (DME) is one of the manifestations of diabetic retinopathy leading to loss of ...
Benjamin Tang, Rushmia Karim
core  

Surgical treatment of diabetic macular edema

open access: yes, 2006
Diabetic macular edema is the most common cause of visual impairment in diabetic patients. Precise pathophysiology of diabetic macular edema is unclear and seems to be multifactorial and includes pericyte loss, microaneurysm formation, basement membrane ...
Aboutable, Tarek
core  

Home - About - Disclaimer - Privacy